CD247 and graft versus host disease: Moreover, while both the DAP12- and CD3ζ-CARs eliminated tumors, mice treated with CD3ζ-based CARs exhibited significant weight loss (>15%), signs of graft-versus-host disease (GvHD), and hepatic necrosis and bile duct hyperplasia.